Sansure Biotech Inc.

SHSE:688289 Stok Raporu

Piyasa değeri: CN¥13.9b

Sansure Biotech Yönetim

Yönetim kriter kontrolleri 3/4

Sansure Biotech CEO'su Lizhong Dai, Jul2019 tarihinde atandı, in görev süresi 5.33 yıldır. şirketin hisselerinin 33.21% doğrudan sahiptir ve bu hisselerin değeri CN¥ 4.63B dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.3 yıl ve 5.3 yıldır.

Anahtar bilgiler

Lizhong Dai

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi5.3yrs
CEO sahipliği33.2%
Yönetim ortalama görev süresi5.3yrs
Yönetim Kurulu ortalama görev süresi5.3yrs

Son yönetim güncellemeleri

Recent updates

Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Nov 03
Sansure Biotech's (SHSE:688289) Problems Go Beyond Weak Profit

Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Oct 09
Sansure Biotech Inc.'s (SHSE:688289) 39% Price Boost Is Out Of Tune With Earnings

Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Oct 03
Sansure Biotech (SHSE:688289) Could Be Struggling To Allocate Capital

Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sep 12
Is Sansure Biotech (SHSE:688289) A Risky Investment?

Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Aug 21
Sansure Biotech Inc. (SHSE:688289) Investors Are Less Pessimistic Than Expected

Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Jun 03
Sansure Biotech (SHSE:688289) May Have Issues Allocating Its Capital

Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

May 03
Why Sansure Biotech's (SHSE:688289) Soft Earnings Are Just The Beginning Of Its Problems

Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Apr 26
Sansure Biotech Inc.'s (SHSE:688289) Business Is Trailing The Industry But Its Shares Aren't

Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

Feb 28
Sansure Biotech's (SHSE:688289) Returns On Capital Are Heading Higher

CEO

Lizhong Dai (56 yo)

5.3yrs

Görev süresi

CN¥991,000

Tazminat

Mr. Lizhong Dai is Chairman of the Board and General Manager of Sansure Biotech Inc. from July 2019.

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥991.00k33.21%
CN¥ 4.6b
Peng Zhu
CFO, Deputy GM5.3yrsCN¥1.14m0.067%
CN¥ 9.3m
Xialin Yu
Deputy GM & Director5.3yrsCN¥675.40k0.026%
CN¥ 3.7m
Xu Fan
Deputy GM & Director5.3yrsCN¥1.07m0.054%
CN¥ 7.5m
Jia Liu
Deputy GM & Directorno dataCN¥1.03m0.035%
CN¥ 4.9m
Zhongping Deng
Deputy General Manager5.8yrsCN¥973.70k0.019%
CN¥ 2.6m
Jun Zhou
Deputy General Manager5.3yrsCN¥1.11m0.016%
CN¥ 2.2m
Liu Kai
Deputy General Manager3.3yrsCN¥1.90m0.026%
CN¥ 3.6m
Jian Zhu
Deputy General Manager3.3yrsCN¥3.05m0.025%
CN¥ 3.4m
Haixiao Wang
Deputy General Manager2.3yrsCN¥2.15m0.041%
CN¥ 5.7m
Xiaoyan Xiong
Deputy General Manager2.1yrsCN¥868.70k0.022%
CN¥ 3.1m

5.3yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim: 688289 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Lizhong Dai
Chairman of the Board & GM5.3yrsCN¥991.00k33.21%
CN¥ 4.6b
Peng Zhu
CFO, Deputy GM4.8yrsCN¥1.14m0.067%
CN¥ 9.3m
Xialin Yu
Deputy GM & Director5.3yrsCN¥675.40k0.026%
CN¥ 3.7m
Xu Fan
Deputy GM & Director4.1yrsCN¥1.07m0.054%
CN¥ 7.5m
Jia Liu
Deputy GM & Director2.3yrsCN¥1.03m0.035%
CN¥ 4.9m
Wu Tan
Chairman of Supervisory Board5.3yrsVeri yok0.035%
CN¥ 4.9m
Ya Cao
Independent Director5.3yrsCN¥75.00kVeri yok
Yuan Fang
Director5.3yrsVeri yokVeri yok
Ling Lin
Supervisor2.3yrsVeri yok0.00040%
CN¥ 55.7k

5.3yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 688289 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).